BAY 3427080, BAY 3427080 60 mg capsules placebo
21656
Phase 3 small_molecule active
Quick answer
BAY 3427080, BAY 3427080 60 mg capsules placebo for Vasomotor symptoms caused by adjuvant endocrine therapy in women with, or at high risk for developing hormone-receptor positive breast cancer is a Phase 3 program (small_molecule) at Bayer AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer AG
- Indication
- Vasomotor symptoms caused by adjuvant endocrine therapy in women with, or at high risk for developing hormone-receptor positive breast cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active